• potent inhibitor of the VEGFR-2 and basic fibroblast growth factor (FGF) kinases (IC50 = 11 and 9 nM, respectively). It is selective relative to epidermal growth factor receptor, platelet-derived growth factor ß, and other related TKs. It also inhibits VEGF-stimulated autophosphorylation of VEGFR-2 in a whole cell assay with an IC50 value of 6 nM
OTAVAchemicals Catalogue Number: 1156353
CAS Registry Number: 252003-65-9
Purity: 95%+ (HPLC)
Ref.: Beebe et al. Pharmacological Characterization of CP-547,632, a Novel Vascular Endothelial Growth Factor Receptor-2 Tyrosine Kinase Inhibitor for Cancer Therapy. Cancer Research (2003), 63, 7301-7309
Abstract: CP-547,632 is a well-tolerated, orally-bioavailable inhibitor presently under clinical investigation for the treatment of human malignancies.